Coronavirus and Pregnancy
Adapted from "SART and ASRM issue advice for infertility patients concerning the novel coronavirus (COVID-19)"
The Society for Assisted Reproductive Technologies (SART) and the American Society for Reproductive Medicine (ASRM) have issued the following recommendations regarding the coronavirus (COVID-19) outbreak:
There is growing evidence that the epidemic is spreading globally. It is important to note that at this point, we are still learning about this virus, and little is known about its impact on reproduction and pregnancy.
Therefore, ASRM and SART suggest that individuals who are pregnant or seeking to initiate a pregnancy soon avoid non-essential travel to known areas of infection or contact with potentially infected individuals. This advice applies to both men and women.
Patients, including prospective egg and sperm donors, as well as surrogate carriers, who meet the diagnostic criteria for COVID-19 infection, should avoid becoming pregnant. If they are undergoing active infertility treatment, we suggest that these patients consider freezing all eggs or embryos and avoiding an embryo transfer until they are disease-free.
All reproductive health care professionals and their patients are encouraged to stay abreast of the latest guidelines and updates issued by the U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) websites regarding evolving developments concerning the COVID-19 epidemic.
Additional information can be obtained at: